Orion Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Orion Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.95K	Hold	50	–	–	﹤0.01%	416
2026 Q1	$6.41K	Hold	50	–	–	﹤0.01%	387
2025 Q4	$6.12K	Hold	50	–	–	﹤0.01%	418
2025 Q3	$5.01K	Hold	50	–	–	﹤0.01%	438
2025 Q2	$4.15K	Hold	50	–	–	﹤0.01%	417
2025 Q1	$4.05K	Hold	50	–	–	﹤0.01%	410
2024 Q4	$4.5K	Buy	+50	New	+$4.84K	﹤0.01%	410
2023 Q2	–	Sell	-61	Closed	-$4.65K	–	430
2023 Q1	$4.65K	Hold	61	–	–	﹤0.01%	404
2022 Q4	$5.06K	Hold	61	–	–	﹤0.01%	344
2022 Q3	$5K	Hold	61	–	–	﹤0.01%	359
2022 Q2	$5K	Hold	61	–	–	﹤0.01%	370
2022 Q1	$5K	Hold	61	–	–	﹤0.01%	378
2021 Q4	$7K	Hold	61	–	–	﹤0.01%	334
2021 Q3	$8K	Buy	+61	New	+$7.86K	﹤0.01%	317

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Orion Capital Management's XBI Position: Q2 2026 in Review

Orion Capital Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 50 shares worth $7.95K. The position accounts for ﹤0.01% of the portfolio, ranked #416.

Orion Capital Management first reported a position in XBI in Q3 2021 and has held it in 14 quarters since. The position peaked at $8K in Q3 2021. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Orion Capital Management held 50 shares of State Street SPDR S&P Biotech ETF worth $7.95K as of Q2 2026.
Orion Capital Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Orion Capital Management's portfolio in Q2 2026, its #416 holding.
Orion Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2021 and has held it in 14 quarters since.
Orion Capital Management's State Street SPDR S&P Biotech ETF position peaked at $8K in Q3 2021.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Orion Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.